Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000549854 | SCV000643410 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2018-01-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000600882 | SCV000714784 | likely benign | not specified | 2017-10-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Center for Advanced Laboratory Medicine, |
RCV000852838 | SCV000995568 | likely benign | Cardiomyopathy | 2017-03-17 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV004799217 | SCV001468749 | uncertain significance | Dilated cardiomyopathy 1G; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2019-07-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002438407 | SCV002753371 | likely benign | Cardiovascular phenotype | 2019-06-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |